Questcor Pharmaceuticals, Inc.

Questcor Pharmaceuticals, Inc. is a specialty pharmaceutical company that serves the needs of the acute care and critical care hospital markets with its proprietary products including HP Acthar(R) Gel for a seizure complex, referred to as West Syndrome or infantile spasm, and patients with multiple sclerosis, Ethamolin(R) for sclerotherapy Glofil(tm)-125 and Inulin for measuring renal GFR and Pramidin(R) for various gastrointestinal disorders including nausea and vomiting. Questcor's clinical stage pipeline products are being developed to treat delayed onset emesis (vomiting), congenital lactic acidosis (CLA), and various central nervous system disorders. As part of a strategy to develop its products globally, Questcor has entered into over 20 contractual relationships with public and private companies including: Ahn-Gook Pharmaceuticals of Korea; Aventis of Pharmaceuticals Inc. of Bridgewater, NJ; CSC Pharmaceuticals HandelsGmbH of Vienna, Austria; Crinos Group of Como, Italy; Dainippon Pharmaceutical Co., Ltd., of Osaka, Japan; Rigel, Inc. of South San Francisco, CA, Sigma-Tau Finanziaria S.p.A of Rome, Italy, Tularik, Inc. of South San Francisco, CA and VSL Pharmaceuticals of Ft. Lauderdale, FA.